Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology
Clinical Trials: Solid Tumors
A listing of clinical trials currently looking for volunteers to enroll in Solid Tumors studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : University of Alabama at Birmingham
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Arizona
Scottsdale : Mayo Clinic
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Scottsdale : GSK Investigational Site
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Scottsdale : TGen Clinical Research Services at Scottsdale Healthcare
A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Scottsdale : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Scottsdale : TGEN Clinical Research Services at Scottsdale Healthcare
Dose Escalation Study of NKP-1339 to Treat Advanced Solid Tumors
View More »
Scottsdale : TGEN Clinical Research Services at Scottsdale Healthcare
Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid Tumors
Scottsdale : TGen Clinical Research Service at Scottsdale Healthcare
Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid Tumors
Scottsdale : Pinnacle Oncology
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma
Scottsdale : TGen Clinical Research Service at Scottsdale Healthcare
Safety Study of PLX108-01 in Patients With Solid Tumors
Scottsdale : TGen Clinical Research Services at Scottsdale Healthcare
Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma
Scottsdale : TGen Clinical Research Service
Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors
Tucson : GSK Investigational Site
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Tucson : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Tucson : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
California
Duarte : City of Hope Updated
A Phase I, Open-Label Multi-Center, Randomized Crossover Study to Assess the Bioequivalence of 2 Formulations TKI258, FMI Capsule and FMI Tablet,in Patients with Advanced Solid Tumors
Duarte : City of Hope Updated
A Phase I/Ib, Dose-Escalating Study of the Safety of Intravenous CALAA-01 in Adults with Solid Tumors Refractory to Standard-of-Care Therapies
Duarte : City of Hope Updated New
An Open-Label, Phase I/Ib Dose Escalation Study to Assess the Safety and Tolerability of GSK 1120212 in Combination with Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, or nab-Paclitaxel in Subjects with Advanced Solid Tumors
Duarte : City of Hope
COG ALTE03N1: Key Adverse Events After Childhood Cancer
Duarte : City of Hope Updated
Evaluation of BCL-XL Specific Immunity
Duarte : City of Hope
Innovative Underserved Community-Based Cancer Risk Screening
Duarte : City of Hope Updated
Phase I Trial of Intraperitoneal nab-Paclitaxel (Abraxane) in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity
Duarte : City of Hope Updated
PHI-55 NCI#7427: A Phase I Study of Halichondrin B Analog (E7389) in Combination with Cisplatin in Advanced Solid Tumors
Duarte : City of Hope Updated
PHI-61 NCI#7967: A Phase I Study of ABT-888 in Combination with Carboplatin and Paclitaxel in Advanced Solid Malignancies
Duarte : City of Hope Updated
Sperm Banking Among Adolescents Newly Diagnosed with Cancer: Development of a Profiling and Referral Tool
View More »
Berkley : Sutter East Bay Hospitals
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
Beverly Hills : Tower Cancer Research Foundation
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma
Fullerton : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Greenbrae : Marin Cancer Care
A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
La Jolla : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Los Angeles : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Los Angeles : University of Southern California (U.S.C.)/ Norris Comprehensive Cancer Center
Phase I Abraxane Weekly and Three Weekly Schedule With Vandetanib
Los Angeles : UCLA
Safety Study of PLX108-01 in Patients With Solid Tumors
Rancho Mirage : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Redondo Beach : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Sacramento : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Sacramento : University of California Davis Cancer Center
Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors
Sacramento : University of California at Davis
Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer
San Francisco : Research Site
Panitumumab Pediatric Study
Santa Maria : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Santa Monica : Call for Information
A Dose Escalation Study of MK1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001 AM7)
Colorado
Aurora : Pfizer Investigational Site
A Trial In Patients With Advanced Cancer And Leukemia
Aurora : Children's Hospital Colorado
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Aurora : University of Colorado Cancer Center Updated
Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Patients With Solid Tumors
Denver : Rocky Mountain Cancer Centers - Denver
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Florida
Fort Lauderdale : Holy Cross Hospital
Immunogen 007
Fort Lauderdale : Holy Cross Hospital
TL32711-POC-0078-PTL
Tampa : H. Lee Moffitt Cancer Center & Research Institute
An Open-Label, Dose-Escalation, Phase 1 Study of MLN9708, a Second-Generation Proteasome Inhibitor, in Adult Patients with Advanced Nonhematologic Malignancies.
View More »
Fort Myers : GSK Investigational Site
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Fort Myers : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Hialeah : Palm Springs Research Institute
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
Ocala : Ocala Oncology Center
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Orlando : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Tampa : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Tampa : Moffitt Cancer Center
Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid Tumors
Georgia
Savannah : Memorial Health University Medical Center
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer COG ABTR01B1
View More »
Atlanta : Taofeek Owonikoko, MD, PhD
A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies
Atlanta : GSK Investigational Site
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Atlanta : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Illinois
Elgin : Sherman Health
Pts Receiving Zoledronate
Osteonecrosis of the Jaw (ONJ) Incidence
SWOG S0702: Prospect Obs Study Assess Incidence ONJ pts start Zoledronic acid bone mets Multiple Myeloma, Solid Tumors or other malig.
View More »
Chicago : Pfizer Investigational Site
A Trial In Patients With Advanced Cancer And Leukemia
Chicago : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Chicago : Northwestern University
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma
Harvey : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Joliet : Joliet Oncology-Hematology Associates, Ltd.
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
Quincy : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Indiana
Indianapolis : Indiana University Simon Cancer Center IU Simon Cancer Center Clinical Research Office, RT 380
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Lafayette : Horizon Oncology Center
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Lafayette :
Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors
Kentucky
Lexington : University of Kentucky-Markey Cancer Center Clinical Research Organization
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
Louisiana
New Orleans : Ochsner Clinic Foundation
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Maryland
Baltimore : Research Site
A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors
Baltimore : University of Maryland Greenebaum Cancer Center
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma
Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Updated
Study Determining the Safety and Tolerability of Combination Therapy With Pazopanib and GSK1120212 in Advanced Solid Tumors Enriched With Patients With Advanced Differentiated Thyroid Cancer
Baltimore : Saint Agnes Healthcare
Study to Evaluate Effect of a Single Dose of Sotatercept (ACE-011) on Red Blood Cell Mass and Plasma Volume in Subjects With Solid Tumors
Baltimore : Weinberg Cancer Institution at Franklin Square
Study to Evaluate Effect of a Single Dose of Sotatercept (ACE-011) on Red Blood Cell Mass and Plasma Volume in Subjects With Solid Tumors
View More »
Bethesda : NCI, CCR
Open Label Study to Evaluate the Safety and Tolerability of GI-6301 a Vaccine Consisting of Whole Heat-Killed Recombitant Yeast Genetically Modified to Express Brachyury Protein in Adults With Solid Tumors
Massachusetts
Cambridge : MedComm
Advanced solid tumors including castration-resistant prostate cancer (CRPC)
View More »
Boston : Call for Information
A Dose Escalation Study of MK1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001 AM7)
Boston : Novartis Investigative Site
A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors
Boston : Pfizer Investigational Site
A Trial In Patients With Advanced Cancer And Leukemia
Boston : Massachusetts General Hospital
BKM120 in Cancers With PIK3CA Activating Mutations
Boston : Dana-Farber Cancer Institute
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Boston : Beth Israel Deaconess Medical Center
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Boston : Dana-Farber Cancer Institute
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Boston : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Boston : Investigational Site Number 840001
Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors
Boston : Investigational Site Number 840002
Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors
Boston : Beth Israel Deaconess Medical Center
Safety Study of PLX108-01 in Patients With Solid Tumors
Boston : Dana Farber Cancer Institute
Safety Study of PLX108-01 in Patients With Solid Tumors
Boston : Massachusetts General Hospital
Safety Study of PLX108-01 in Patients With Solid Tumors
Boston : Beth Israel Deaconess Medical Center
Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors
Boston : Dana Farber Cancer Institute
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Boston : Beth Israel Deaconess Medical Center (BIDMC) - Cancer Center
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Boston : Massachusetts General Hospital Cancer Center
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Michigan
Ann Arbor : University of Michigan
An Open-Label, Dose-Escalation, Phase 1 Study of MLN9708, a Second-Generation Proteasome Inhibitor, in Adult Patients with Advanced Nonhematologic Malignancies.
View More »
Ann Arbor : University of Michigan Comprehensive Cancer Center
A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors
Ann Arbor : University of Michigan Comprehensive Cancer Center
A Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors
Ann Arbor : University of Michigan Cancer Center
Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas
Detriot : Karmanos Cancer Institute
A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Detroit : GSK Investigational Site
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Detroit : Wayne State University Department of Oncology Karmanos Cancer Institute
A Study of DS-2248, in Subjects With Advanced Solid Tumors
Detroit : Pfizer Investigational Site
A Trial In Patients With Advanced Cancer And Leukemia
Detroit : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Detroit : Wayne State University, Division of Hematology/Oncology, Karmanos Cancer Institute
Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid Tumors
Detroit : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Detroit : Karmanos Cancer Institute
Safety Study of AB0024 in Patients With Advanced Solid Tumors
Detroit : Wayne State University/Karmanos Cancer Institute
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Detroit : Henry Ford Health System Protocol Review Committee Updated
Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Patients With Solid Tumors
Grand Rapids : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Minnesota
Minneapolis : Minnesota Oncology Hematology P.A.
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Minneapolis : Research Site
Panitumumab Pediatric Study
Minneapolis : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Rochester : Mayo Clinic
Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas
St. Louis Park : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Mississippi
Jackson : Investigational Site Number 840002
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
Missouri
St. Louis : Washington University School of Medicine Updated
Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Patients With Solid Tumors
Nevada
Las Vegas : Comprehensive Cancer Centers of Nevada
Safety Study of PLX108-01 in Patients With Solid Tumors
New Hampshire
Lebanon : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Lebanon : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
New Jersey
Hackensack : Haceknasack University Medical Center
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma
Morristown : Morristown Memorial Hospital
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
New Brunswick : Cancer Institute of New Jersey
Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid Tumors
New Mexico
Albuquerque : Research Site
A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors
New York
Bronx : Einstein-Montefiore Institute for Clinical & Translational Research Updated New
A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy
Bronx : Einstein-Montefiore Institute for Clinical & Translational Research Updated New
Phase I Safety Study of Clostridium Novyi-NT Spores in Patients with Treatment-Refractory Solid Tumor Malignancies
Bronx : Biomedical Research Alliance of New York
Solid Tumors
Bronx : Biomedical Research Alliance of New York
Solid Tumors - Adults
View More »
Bronx : Montefiore Medical Center
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
Buffalo :
Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors
Great Neck : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
New York : Call for Information
A Dose Escalation Study of MK1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001 AM7)
New York : Memorial Sloan Kettering Cancer Center
BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors
New York : Memorial Sloan-Kettering Cancer Center
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
New York : Research Site
Panitumumab Pediatric Study
New York : Mount Sinai Medical Center
Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid Tumors
New York : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
New York : Memorial Sloan-Kettering Cancer Center
Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors
New York city : Department of Radiation oncology, Memorial Sloan Kettering Cancer Center
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
North Carolina
Durham : Duke University
An Open-Label, Dose-Escalation, Phase 1 Study of MLN9708, a Second-Generation Proteasome Inhibitor, in Adult Patients with Advanced Nonhematologic Malignancies.
View More »
Chapel Hill : Novartis Investigative Site
A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors
Charlotte : Blumenthal Cancer Center - Main
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Durham : Duke University Medical Center
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Durham : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Durham : Duke Cancer Institute
Dose Escalation Study of Pazopanib Plus TH-302
Durham : Duke University Medical Center
Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas
Durham : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Durham : Duke University Medical Center
Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors
Winston Salem : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
North Dakota
Bismarck : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Bismarck : Mid Dakota Clinical P.C. - Cancer Treatment and Research Center
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
Ohio
Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
ADVL0612: A Phase I Study of Sunitinib (SU11248), an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Children with Refractory Solid Tumors
Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
ADVL0815: A Phase I Study of Pazopanib as a Single Agent for Children with Refractory Solid Tumors
Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
ADVL0816: A Phase I Study of Obatoclax (Pan Anti-Apoptotic BCL-2 Family Small Molecule Inhibitor), in Combination with Vincristine/Doxorubicin/Dexrazoxane, in Children with Relapsed/Refractory Solid Tumors or Leukemia
Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
Phase I Study of the RAF Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib in Children with Refractory Solid Tumors or Refractory Leukemias
Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
VITAC: A Pilot Study of the Addition of Bevacizumab to Vincristine, Oral Irinotecan and Temozolomide (VOIT regiment) for Relapsed/Refractory Pediatric Solid Tumors
View More »
Canton : Gabrail Cancer Center
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
Cincinnati :
Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors
Cleveland : University Hospitals Case Medical Center
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Columbus : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Columbus : The Ohio State University - Comprehensive Cancer Center
Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma
Middletown : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Oklahoma
Oklahoma City : University of Oklahoma Health Sciences Center
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Oklahoma City : Oklahoma University Cancer Institute
Phase I Dose Escalation Study of the Safety and Pharmacokinetics of ME-143 Single Agent for Refractory Solid Tumors
Oregon
Bend : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Eugene : Willamette Valley Cancer and Research / USOR
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Portland : Research Site
Panitumumab Pediatric Study
Portland : Oregon Health and Sciences University
Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant Gliomas
Portland : Providence Cancer Center
Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant Gliomas
View More »
Tulatin : Northwest Cancer Specialists, P.C.
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Pennsylvania
Philadelphia : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Philadelphia :
Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors
Philadelphia : Pennsylvania Oncology Hematology Associates
Safety Study of PLX108-01 in Patients With Solid Tumors
Philadelphia : Fox Chase Cancer Center Updated
Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Patients With Solid Tumors
Philadelphia : Pennsylvania Oncology
Study to Evaluate Effect of a Single Dose of Sotatercept (ACE-011) on Red Blood Cell Mass and Plasma Volume in Subjects With Solid Tumors
View More »
Pittsburgh : UPMC Shadyside Radiation Oncology
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Rhode Island
Providence : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
South Carolina
Charleston : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Greenville : Saint Francis Hospital
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Tennessee
Nashville : Sarah Cannon Research Institute
An Open-Label, Dose-Escalation, Phase 1 Study of MLN9708, a Second-Generation Proteasome Inhibitor, in Adult Patients with Advanced Nonhematologic Malignancies.
View More »
Knoxville : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Memphis : GSK Investigational Site
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Memphis : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Memphis : Call for Information (Investigational Site 0005)
Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1)
Nashville : GSK Investigational Site
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Nashville : Novartis Investigative Site
A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors
Nashville : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Nashville : The Sarah Cannon Research Institute
Dose Escalation Study of NKP-1339 to Treat Advanced Solid Tumors
Nashville : Vanderbilt University
IDO Inhibitor Study for Relapsed or Refractory Solid Tumors
Nashville : Investigational Site Number 840003
Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors
Nashville : The Sarah Cannon Research Institute
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma
Nashville : Tennessee Oncology, PLLC
Phase I Dose Escalation Study of the Safety and Pharmacokinetics of ME-143 Single Agent for Refractory Solid Tumors
Nashville : Vanderbilt-Ingram Medical Center
Safety Study of PLX108-01 in Patients With Solid Tumors
Nashville : Sarah Cannon Research Institute Tennessee Oncology Drug Development Unit
Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma
Texas
Dallas : Texas Oncology - Medical City Dallas
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Dallas : UT Southwestern Medical Center - Simmons Cancer Center
Clinical Trial of ARQ 761 in Advanced Solid Tumors
Dallas : Mary Crowley Cancer Research Center
Phase 1 Study of ONT-10 in Patients With Solid Tumors
Dallas : Mary Crowley Cancer Research Centers
Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic Cancer
Dallas : Texas Oncology, PA (North)
Safety Study of PLX108-01 in Patients With Solid Tumors
View More »
Dallas : Mary Crowley Cancer Research Centers
Trial of Bi-shRNA-furin and Granulocyte Macrophage Colony Stimulating Factor (GMCSF) Augmented Autologous Tumor Cell Vaccine for Advanced Cancer
Fort Worth : Texas Oncology - Fort Worth 12th Avenue
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Fort Worth : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Houston : Research Site
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0639 in Advanced Solid Tumors
Houston : The University of Texas M. D. Anderson Cancer Center
A Study of QBI-139 in Subjects With Advanced Solid Tumors
Houston : Pfizer Investigational Site
A Trial In Patients With Advanced Cancer And Leukemia
Houston : MD Anderson Cancer Center / University of Texas
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Houston : M.D. Anderson Cancer Center
First-in-Man, Dose-escalation Trial of c-Met Kinase Inhibitor EMD 1204831 in Subjects With Advanced Solid Tumors
Houston : Research Site
Panitumumab Pediatric Study
Houston : UT MD Anderson Cancer Center
Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients
Houston : MD Anderson Cancer Center Updated
Study Determining the Safety and Tolerability of Combination Therapy With Pazopanib and GSK1120212 in Advanced Solid Tumors Enriched With Patients With Advanced Differentiated Thyroid Cancer
Paris : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Round Rock : Texas Oncology - Central Austin Cancer Center
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
San Antonio : South Texas Accelerated Research Therapeutics
A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors
San Antonio : South Texas Accelerated Research Therapeutics
A Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors
San Antonio : South Texas Accelerated Research Therapeutics, LLC
A Study of DS-2248, in Subjects With Advanced Solid Tumors
San Antonio : START - South Texas Accelerated Research Therapeutics, LLC
Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffein, Midazolam, and Digoxin in Cancer Subjects
San Antonio : South Texas Accelerated Research Therapeutics, LLC
Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid Tumors
San Antonio : Cancer Therapy and Research Center
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
San Antonio : South Texas Accelerated Research Therapeutics (START)
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma
San Antonio : South Texas Accelerated Research Therapeutics
Safety Study of AB0024 in Patients With Advanced Solid Tumors
San Antonio : South Texas Accelerated Research Therapeutics, LLC (START)
Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma
San Antonio : University of Texas Health Science Center San Antonio
Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors
San Antonio : START- South Texas Accelerated Research Therapeutics, LLC
Study of PM060184 in Patients With Advanced Solid Tumors
San Antonio :
Study of REGN910 (SAR307746)
Utah
Salt Lake City : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Virginia
Washington
Seattle : University of Washington- Seattle Cancer Care Alliance
An Open-Label, Dose-Escalation, Phase 1 Study of MLN9708, a Second-Generation Proteasome Inhibitor, in Adult Patients with Advanced Nonhematologic Malignancies.
View More »
Edmonds : Puget Sound Cancer Centers
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Spokane : Evergreen Hematology & Oncology
Safety Study of PLX108-01 in Patients With Solid Tumors
Spokane Valley : Cancer Care Northwest
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Spokane Valley : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Yakima : Yakima Valley Memorial Hospital / North Star Lodge
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Wisconsin
Madison : University of Wisconsin Comprehensive Cancer Center
A Study of QBI-139 in Subjects With Advanced Solid Tumors
Madison : Kenneth DeSantes., MD
Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors
Australia
Bentleigh East : Research Site
A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors
Bentleigh East : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Footscray : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Kogarah : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Kurralta Park : Research Site
A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors
View More »
Kurralta Park : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Parkville : Research Site
A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors
Parkville : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Parkville : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Randwick : Research Site Updated
Phase I Comparative Bioavailability Study
South Brisbane : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Westmead : Westmead Hospital
Trial of MSC1936369B in Subjects With Solid Tumours
Woodville South : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Austria
Graz : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Graz : Glycotope Investigational Site
TrasGEX™: Dose Escalation Study
Innsbruck : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Innsbruck : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Innsbruck : Glycotope Investigational Site
TrasGEX™: Dose Escalation Study
View More »
Salzburg : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Steyr : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Wels : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Wien : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Wien : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Belgium
Aalst : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Bonheiden : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Brasschaat : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Brugge : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Brussels : Jules Bordet Institute
Trial of MSC1936369B in Subjects With Solid Tumours
View More »
Bruxelles : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Charleroi : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Edegem : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Eupen : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Gent : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Gent : Novartis Investigative Site
Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function
Ghent : Ghent University Hospital
Trial of MSC1936369B in Subjects With Solid Tumours
Gilly : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Leuven : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Leuven : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Leuven : Research Site Updated
Phase I Comparative Bioavailability Study
Leuven : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Libramont : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Liege : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Liège : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Mechelen : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Namur : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Oostende : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Sint-Niklaas : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Verviers : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Wilrijk : Research Site
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Wilrijk : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Brazil
Curitba : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
ItajaÃ- : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Porto Alegre : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
São Paulo : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Salvador : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Bulgaria
Varna : MHAT "St.Marina"
Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer
Varna : Oncology Dispensary "Dr. Marko Markov"
Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer
Canada
Toronto, Ontario : Princess Margaret Hospital
An Open-Label, Dose-Escalation, Phase 1 Study of MLN9708, a Second-Generation Proteasome Inhibitor, in Adult Patients with Advanced Nonhematologic Malignancies.
View More »
Kirkland : Merck Frosst Canada Ltd.
A Dose Escalation Study of MK1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001 AM7)
Montreal : McGill University
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Oshawa : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Ottawa : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Quebec : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Toronto : Princess Margaret Hospital
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Toronto : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Toronto :
Study of REGN910 (SAR307746)
Vancouver : Novartis Investigative Site
A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors
Vancouver : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Czech Republic
Brno : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Hradec Kralove : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Olomouc : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Praha 2 : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Praha 5 : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Denmark
Aalborg : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Herlev : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Odense : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Finland
HUS : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Lahti : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Tampere : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Turku : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
France
Aix en Provencence cedex 01 : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Amiens : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Aubagne : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Besançon Cedex : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Besançon Cedex : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
View More »
Bordeaux : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Bordeaux : Institute Bergonié
Trial of MSC1936369B in Subjects With Solid Tumours
Bourg en Bresse : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Brest cedex : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Brive la Gaillarde : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Caen Cedex 05 : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Carcassonne : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Clermont Ferrand Cedex 1 : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Colmar Cedex : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Courbevoie : Laboratoires Merck Sharp & Dohme - Chibret
Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1)
Dijon : Centre Georges-François Leclerc Updated
Study of Debio 0932 in Patients With Advanced Solid Tumours or Lymphoma
Draguignan Cedex : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
La Roche Sur Yon Cedex 9 : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
La Seyne Sur Mer : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Longjumeau cedex 1 : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Marseille : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Mont de Marsan : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Montauban cedex : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Nancy : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Nantes Cedex 2 : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Orléans : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Paris : Hôpital Beaujon
Trial of MSC1936369B in Subjects With Solid Tumours
Paris : Hopital Saint Louis
Trial of MSC1936369B in Subjects With Solid Tumours
Paris Cedex 20 : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Paris Cedex 8 : Laboratoires Merck Sharp & Dohme - Chibret
A Study of Ridaforolimus in Pediatric Patients With Advanced Solid Tumors (MK-8669-056)
Pessac Cedex : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Pierre Benite Cedex : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Pontoise Cedex : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Prigny : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Reims : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Reims Cedex : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Rennes : Centre Eugène Marquis
Trial of MSC1936369B in Subjects With Solid Tumours
Rouen : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Saint Grégoire cedex : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Saint Quentin : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Soissons : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Toulouse : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Toulouse : Institut Claudius Regaud Updated
Study of Debio 0932 in Patients With Advanced Solid Tumours or Lymphoma
Toulouse : Institute Claudius Regaud
Trial of MSC1936369B in Subjects With Solid Tumours
Vichy cedex : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Villefranche Sur Saone Cedex : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Villejuif : Institut Gustave Roussy Updated
Study of Debio 0932 in Patients With Advanced Solid Tumours or Lymphoma
Villejuif : Institute Gustave Roussy
Study of Oral E-3810, a Dual VEGFR-FGFR Tyrosine Kinase Inhibitor, in Patients With Solid Tumors
Germany
Augsburg : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Berlin : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Berlin : Charité - Universitätsmedizin Berlin
Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer
Berlin : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Bochum : Medizinische Univeritätsklinik Ruhr-Universität Bochum
Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer
View More »
Braunschweig : Klinikum Braunschweig
Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer
Bremerhaven : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Dresden : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Essen : Universitätsklinikum Essen, Innere Klinik (Tumorforschung)
Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer
Frankfurt : Krankenhaus Nordwest, Klinik für Onkologie und Hämatologie
Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer
Frankfurt : Novartis Investigative Site
Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function
Freiburg : University Hospital Freiburg Gynecological Clinic
Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer
Halle : Universitätsklinikum Halle
Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer
Halle (Saale) : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Halle/Saale : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Hamburg : Glycotope Investigational Site
CetuGEX™: Dose Escalation Study
Hamburg : Onkologische Schwerpunktpraxis Eppendorf
Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer
Hamburg : Universitäres Cancer Center Universitätsklinikum Eppendorf
Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer
Hamburg : Glycotope Investigational Site
PankoMab-GEX™: Dose Escalation Study
Hamburg : University Hospital Hamburg-Eppendorf
Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer
Heidelberg : Glycotope Investigational Site
CetuGEX™: Dose Escalation Study
Heidelberg : Universitätsklinikum Heidelberg, NCT
Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer
Köln : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Kassel : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Kassel : Hospital Kassel
Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer
Leipzig : Universitätsklinikum Leipzig
Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer
Münster : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Mainz : Universitätsmedizin der Johannes-Gutenberg Universität
Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer
Mainz : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Mannheim : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Mannheim : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Marburg : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Muenchen : Klinikum rechts der Isar
Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer
Neunkirchen : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Rotenburg (Wümme) : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Stralsund : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Ulm : Universitätsklinikum Ulm
Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer
Villingen-Schwenningen : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Würselen : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Würzburg : University Hospital Würzburg
Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer
Greece
Athens : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Heraklion : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Patra : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Thessaloniki : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Hong Kong
Kowloon : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Sha Tin : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Tuen Mun : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Hungary
Budapest : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Debrecen : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Gyor : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Israel
Petach Tikva : Rabin Medical Center
Evaluation of [18F]-ML-10 as a PET Imaging Radiotracer for Early Detection of Response of Brain Metastases to Whole Brain Radiation Therapy
Italy
Bologna : Pfizer Investigational Site
A Trial In Patients With Advanced Cancer And Leukemia
Cefalù : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Genova : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Messina : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Milan : Instituto Europeo di Oncologia
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
View More »
Milan : Glycotope Investigational Site
CetuGEX™: Dose Escalation Study
Milan : Glycotope Investigational Site
PankoMab-GEX™: Dose Escalation Study
Milano : European Institute of Oncology
Study of Oral E-3810, a Dual VEGFR-FGFR Tyrosine Kinase Inhibitor, in Patients With Solid Tumors
Napoli : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Napoli : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Padova : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Roma : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
San Giovanni Rotondo (FG) : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Torino : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Japan
Chuo-ku : National Cancer Center Hospital
Dose-Finding Study of Cabozantinib in Japanese Subjects With Advanced Cancer
Kashiwa : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Mitaka-city : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Nagoya-city : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Sunto-gun : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
View More »
Tokyo :
A Study of LY2523355 in Patients With Solid Cancer
Tokyo : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Yokohama-city : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Korea, Republic of
Seoul : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Seoul : Novartis Investigative Site
Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
Latvia
Liepaja : Piejuras Hospital
Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer
Riga : Paula Stradina Clinical University Hospital
Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer
Riga : Riga East Clinical Research
Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer
Lithuania
Kaunas : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Vilnius : Vilnius University
Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer
Vilnius : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Netherlands
Amstelveen : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Amsterdam : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Amsterdam : Nationaal Kanker Instituut (NKI)
GLPG0187: Safety, Tolerability and Pharmacokinetics in Patients With Solid Tumors
Amsterdam : Netherlands Cancer Institute - Antonie van Leeuwenhoek Hospital
Trial of MSC1936369B in Subjects With Solid Tumours
Dordrecht : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
View More »
Eindhoven : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Enschede : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Groningen : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Haarlem : Merck Sharp & Dohme B.V.
A Dose Escalation Study of MK1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001 AM7)
Leiden : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Leiderdorp : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Maastricht : Novartis Investigative Site
Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function
Purmerend : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Utrecht : Universitair Medisch Centrum
GLPG0187: Safety, Tolerability and Pharmacokinetics in Patients With Solid Tumors
Vlissingen : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Zutphen : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Poland
Bialystok : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Gdansk : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Gdansk : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Konin : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Koszalin : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
View More »
Krakow : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Lodz : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Lubin : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Lublin : III Oddzial Onkologii Ginekologicznej
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Olsztyn : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Poznan : Klinika Onkologii AM w Poznaniu
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Poznan : Oddzial Radioterapii
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Poznan : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Walbrzych : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Warszawa : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Wroclaw : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Portugal
Barreiro : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Lisboa : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Porto : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Romania
Alba Iulia : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Baia-Mare : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Brasov : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Bucharest : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Bucuresti : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
View More »
Cluj Napoca : Institutul Oncologic Prof. Dr. Ion. Chiricuta Sectia de Oncologie Medicala
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Cluj Napoca : Institutul Oncologic Prof. Dr. Ion. Chiricuta Sectia Radiologie
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Cluj Napoca : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Cluj-Napoca : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Cluj-Napoca : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Iasi : Oncology Medical Centre SCM
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Mures : Clinical Caunty Hospital Mures
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Oradea : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Ramnicu Valcea : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Sibiu : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Targu Mures : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Timisoara : Research Site Updated
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Russian Federation
Chelyabinsk : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Moscow : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Saint Petersburg : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Samara : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Serbia
Belgrade : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Sremska Kamenica : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Slovakia
Bardejov : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Bratislava : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Kosice : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Nitra : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Poprad : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Slovenia
Ljubljana : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Spain
A Coruña : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Badalona : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Barcelona : Novartis Investigative Site
A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors
Barcelona : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Elche : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
View More »
Madrid : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Santander : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Sweden
Eskilstuna : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Linköping : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Uppsala : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Switzerland
Basel : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Bellinzona : Ospedale San Giovanni
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Bellinzona : Glycotope Investigational Site
CetuGEX™: Dose Escalation Study
Bellinzona : Glycotope Investigational Site
PankoMab-GEX™: Dose Escalation Study
Bellinzona : Research Site Updated
Phase I Comparative Bioavailability Study
View More »
Geneva 14 : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
St.Gallen : Kantonsspital St. Gallen
Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer
Winterthur : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Taiwan
Gueishan Township : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Niaosong Township : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Tainan : National Cheng Kung University Hospital
A Dose Escalation Study of SCB01A in Subjects With Advanced Solid Tumors Who Have Failed Standard Therapy
Taipei : Novartis Investigative Site
Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
Taipei City : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
United Kingdom
Belfast : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Birmingham : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Cottingham : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Edinburgh : Research Site Updated
Phase I Comparative Bioavailability Study
Hoddesdon : Merck Sharp & Dohme Ltd.
A Study of Ridaforolimus in Pediatric Patients With Advanced Solid Tumors (MK-8669-056)
View More »
Hoddesdon : Merck Sharp & Dohme Ltd.
Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1)
Hoddesdon : Merck Sharp & Dohme Ltd.
Study of Safety and Pharmacokinetics of MK-8242 in Participants With Advanced Solid Tumors (P07650 AM1)
Leicester : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
London : University College Hospital
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
London : Royal Marsden Hospital
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
London : Investigator Sites
Study of CH5132799 Administered Orally in Patients With Advanced Solid Tumors
Manchester : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Manchester : Research Site Updated
Phase I Comparative Bioavailability Study
Newcastle : Research Facility Updated
Phase I Comparative Bioavailability Study
Northampton : Research Site Updated
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Northwood : Mount Vernon Cancer Center
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Northwood : Research Site Updated
Phase I Comparative Bioavailability Study
Oxford : Churchill Hospital
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Oxford : Research Site Updated
Phase I Comparative Bioavailability Study
Sutton : Drug Development Unit Royal Mardsen NHS Foundation Trust
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Sutton : Research Site Updated
Phase I Comparative Bioavailability Study
Sutton : Royal Marsden Hospital
Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma
United States
Washington : GSK Investigational Site
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Washington : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Washington : Research Site
Panitumumab Pediatric Study
Washington : Georgetown Lombardi Comprehensive Cancer Center
Phase I Study of CS-7017 and Bexarotene
